Actively Recruiting
JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors
Led by University Hospital Heidelberg · Updated on 2024-10-15
250
Participants Needed
1
Research Sites
378 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
JUMP\_START aims to assess the needs of individuals aged ≤ 50 years with gastrointestinal (GI) tumors and implement a tailored support and counseling program at the University Hospital Heidelberg and the National Center for Tumor Diseases (NCT). In phase 1A, 12-15 individuals aged ≤ 50 years with GI tumors will be interviewed via telephone using semi-structured interviews to obstain a detailed understanding of the life situation, the burdens, and the care situation within the structures of the NCT Heidelberg. In phase 1B, the care networks of young patients with GI tumors beyond the NCT, including the analysis of changes and important access routes/possible gatekeepers, will be explored using so-called ego-centered network analyses, in comparison with patients who received a GI tumor diagnosis after the age of 50. In response to the results of phase 1A and 1B, the care services for young patients with GI tumors will be optimized, and tailored counseling programs will be developed in phase 2. These project phases will be accompanied by Quality of Life assessments using European Organisation for Research and Treatment of Cancer (EORTC) questionnaires. All patients with GI tumors (regardless of potential inclusion in phase 1A or 1B) will receive the EORTC questionnaires once. In phase 2, Quality of Life will be assessed every 6 months.
CONDITIONS
Official Title
JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals aged 18 to 50 years receiving treatment for a gastrointestinal tumor at the Heidelberg University Hospital
- Sufficient knowledge of the German language
- Capable of providing informed consent
- Additional recruitment for Phase 1B and Quality of Life assessments: Patients with gastrointestinal tumor aged 51 years or older
You will not qualify if you...
- Individuals diagnosed with a gastrointestinal tumor after age 50 (except for Phase 1B and Quality of Life assessments)
- Individuals diagnosed with a gastrointestinal tumor under age 18
- Lack of capacity to consent and/or absence of informed consent
- Insufficient knowledge of the German language
- Severe cognitive impairments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Center for Tumor Diseases (NCT) Heidelberg
Heidelberg, Baden-Wurttemberg, Germany, 69120
Actively Recruiting
Research Team
B
Bruno C. Köhler
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here